Kevin Daniels - 16 Feb 2023 Form 4 Insider Report for CORE LABORATORIES N V

Signature
/s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
4
Filing time
21 Feb 2023, 14:15:41 UTC
Previous filing
04 Jan 2023
Next filing
04 Dec 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLB Performance Shares Award $0 +12,240 $0.000000 12,240 16 Feb 2023 Common Shares 12,240 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2023 and ends on December 31, 2025 (the "Performance Period"). At the end of the Performance Period, 50% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 100% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 50% up to 100% of the award).